Antioxidant and cytoprotective effects of L-serine on human endothelial cells

Research in Pharmaceutical Sciences

Volumn 7, Issue 4, 2012, Pages 209-215

  Naderi Maralani, M ^a   Movahedian, A ^b   Haghjooy Javanmard, Sh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Heme oxygenase 1; L serine; MTT; Nitric oxide; Nrf2

Indexed keywords

HEME OXYGENASE 1; HYDROGEN PEROXIDE; NITRIC OXIDE; SERINE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL LYSATE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOASSAY; OXIDATIVE STRESS; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84873343373     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis C. Oxidative stress, antioxidant vitamins, and atherosclerosis. Herz. 2003;28:628-638.
2. Tawfik HE, Cena J, Schulz R, Kaufman S. Role of oxidative stress in multiparity-induced endothelial dysfunction. Am J Physiol-Heart C. 2008;295: H1736-H1742.
3. Klouche K, Morena M, Canaud B, Descomps B, Beraud J, Cristol J. Mechanism of in vitro hemeinduced LDL oxidation: effects of antioxidants. Eur J Clin Invest. 2004;34:619-625.
4. Estacion M, Weinberg JS, Sinkins WG, Schilling WP. Blockade of maitotoxin-induced endothelial cell lysis by glycine and L-alanine. American Journal of Physiology-Cell Physiology. 2003;284: C1006-C1020.
5. Movahedian A, Naderi GA, Dashti GR, Asgary S, Zadhoosh F. Antioxidant effects of L-Serine against fatty streak formation in hypercholesterolemic animals. ARYA Atherosclerosis. 2010;2:126-129.
6. Kim J, Cha YN, Surh YJ. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2010;690:12-23.
7. Element AR. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol. 2004;37:139-143.
8. Chen XL, Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH, et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol-Heart C. 2006;290:H1862-H1870.
9. Erdmann K, Grosser N, Schröder H. L-methionine reduces oxidant stress in endothelial cells: role of heme oxygenase-1, ferritin, and nitric oxide. AAPS J. 2005;7:195-200.
10. Grosser N, Oberle S, Berndt G, Erdmann K, Hemmerle A, Schröder H. Antioxidant action of Lalanine: heme oxygenase-1 and ferritin as possible mediators. Biochem Bioph Res Co. 2004;314:351-355.
11. Wang CY, Chau LY. Heme oxygenase-1 in cardiovascular diseases: molecular mechanisms and clinical perspectives. Chang Gung Med J. 2010;33: 13-24.
12. Idriss NK, Blann AD, Lip GYH. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008;52:971-978.
13. Otterbein LE, Choi AMK. Heme oxygenase: colors of defense against cellular stress. Am J Physiol- Lung C. 2000;279:L1029-L1037.
14. Foreman KE, Tang J. Molecular mechanisms of replicative senescence in endothelial cells. Exp Gerontol. 2003;38:1251-1257.
15. Pae HO, Son Y, Kim NH, Jeong HJ, Chang KC, Chung HT. Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide. 2010;23:251-257.
16. Ma ZC, Hong Q, Wang YG, Tan HL, Xiao CR, Liang QD, et al. Ferulic acid protects lymphocytes from radiation-predisposed oxidative stress through extracellular regulated kinase. Int J Radiat Biol. 2011;87:130-140 .
17. Sadeghi-Aliabadi H, Minaiyan M, Dabestan A. Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells. Res Pharm Sci. 2010;5:127-133.
18. Kostyuk VA, Potapovich AI, Suhan TO, de Luca C, Korkina LG. Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. European Journal of Pharmacology. 2011;658:248-256.
19. Rao VA, Klein SR, Bonar SJ, Zielonka J, Mizuno N, Dickey JS, et al. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. JBiol Chem. 2010;285:34447-34459.
20. Kim H, Kim HA, Choi JS, Lee M. Delivery of hypoxia inducible heme oxygenase-1 gene using dexamethasone conjugated polyethylenimine for protection of cardiomyocytes under hypoxia. Bull Korean Chem Soc. 2009;30:897-901.
21. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical biochemistry. 1982;126:131-138.
22. Li L, Shen L, She H, Yue S, Feng D, Luo Z. Nitric oxide-induced activation of NF-κB-mediated NMDA-induced CTP: phosphocholine cytidylyl transferase alpha expression inhibition in A549 cells. Cell Biol Toxicol. 2011;27:41-47.
23. Whang WK, Park HS, Ham IH, Oh M, Namkoong H, Kim HK, et al. Methyl gallate and chemicals structurally related to methyl gallate protect human umbilical vein endothelial cells from oxidative stress. Exp Mol Med. 2005;37:343-352.
24. Raghavan SAV, Dikshit M. Vascular regulation by the-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. 2004;49:397-414.
25. Pae HO, Oh GS, Lee BS, Rim JS, Kim YM, Chung HT. 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis. 2006;187:274-284.
26. Patterson RA, Lamb DJ, Leake DS. Mechanisms by which cysteine can inhibit or promote the oxidation of low density lipoprotein by copper. Atherosclerosis. 2003;169:87-94.
27. Garofalo K, Penno A, Schmidt BP, Lee HJ, Frosch MP, von Eckardstein A, et al. Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type. JClin Invest.2011;121:4735-4745.
28. Mann GE, Rowlands DJ, Li FYL, De Winter P, Siow R. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2- mediated antioxidant gene expression. Cardiovasc Res. 2007;75:261-274.
29. Heiss EH, Schachner D, Werner ER, Dirsch VM. Active NF-E2-related Factor (Nrf2) Contributes to Keep Endothelial NO Synthase (eNOS) in the Coupled State. Journal of Biological Chemistry. 2009;284:31579-31586.
30. Góra-Kupilas K, Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 2005;43:31-39.
31. Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol. 2000;60:1121-1128.
32. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. JClin Invest. 1999;103:129-135.
33. de Haro Miralles J, Martinez-Aguilar E, Florez A, Varela C, Bleda S, Acin F. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs. Interactive CardioVascular and Thoracic Surgery. 2009;9:107-112.
34. Weinberg JM, Davis JA, Abarzua M, Rajan T. Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. JClin Invest. 1987;80:1446-1454.
35. Weinberg J, Varani J, Johnson K, Roeser N, Dame M, Davis J, et al. Protection of human umbilical vein endothelial cells by glycine and structurally similar amino acids against calcium and hydrogen peroxide-induced lethal cell injury. Am J Pathol. 1992;140:457-471.